Arrowstreet Capital
ALT icon

Arrowstreet Capital’s Altimmune ALT Stock Holding History

Arrowstreet Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,000
Closed -$198K – 2261
2020
Q3 		$198K Buy
+15,000
New +$300K ﹤0.01% 2203
2018
Q1 		– Sell
-1,786
Closed -$107K – 1103
2017
Q4 		$107K Sell
1,786
-375
-17% -$24K ﹤0.01% 1204
2017
Q3 		$150K Sell
2,161
-250
-10% -$18.6K ﹤0.01% 1064
2017
Q2 		$231K Buy
2,411
+235
+11% +$39.1K ﹤0.01% 982
2017
Q1 		$530K Buy
+2,176
New +$1.16M ﹤0.01% 1081

Other funds holding ALT

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return